Introduction
There has been much discussion in recent years about the toxicity and potency of the pertussis content of triple vaccines (whooping-cough, diphtheria, tetanus) used in combined immunization procedures in infancy and early childhood. Hopper (1961) drew attention to illnesses following the administration of pertussis-containing vaccines in infancy, which ranged from local irritation through systemic disturbances to a state of shock or collapse. Haire et al. (1967) thought that reactions recorded after inoculations with triple vaccines, in infants under 6 months of age, were too severe and too frequent to be acceptable and suggested a reduction in the number of pertussis organisms/dose, thereby accepting a loss of potency which might be offset by greater acceptability. Perkins (1967) advised that by decreasing the bacterial content of pertussis these vaccines would be unlikely to retain sufficient immunizing potency, as measured by the mouse protection test, to satisfy the British Therapeutic Substances Requirements.
The appearance of infections due to predominantly type 1,3 strains of Bordetella pertussis in vaccinated and unvaccinated communities has thrown doubt on the effectiveness of pertussis vaccination (Preston, 1965 ; Wilson et al., 1965) . Holt (1967) calculated, from Medical Research Council committee reports (1956a, 1959) , the expected frequency of whooping-cough in a partially vaccinated child community and the proportion of the total to be expected in the vaccinated component. The recent incidence of whooping-cough was much as had been predicted (Muggleton, 1967) . Muggleton (1967) 2-5mg.
Immunization of Children.-Parental permission was sought before infants aged 3 months attending the clinic for primary immunization against diphtheria, tetanus, whooping-cough, and poliomyelitis were included in the trial. The vaccine used was determined by random selection at the time of the first inoculation. Each child returned twice at about four-weekly intervals to complete the schedule of inoculations with the same vaccine. Oral trivalent poliomyelitis vaccine was given at each visit. Vaccines were stored throughout at 4°C. No child with a history of convulsions or allergy was included in the trial. All inoculations were by deep subcutaneous injection into the upper arm or the thigh.
Follow-up.-The infants were visited at home by the same trained nurse on the day following each inoculation. She recorded any symptoms that had occurred since inoculation. Rectal temperature was recorded at each visit and particular attention was paid to generalized reactions-crying, fretfulness, drowsiness, vomiting, anorexia, and rash. Reactions localized to the site of inoculation-erythema, induration, swelling, and tenderness-were also recorded.
Parental permission was granted for a number of babies to be bled before their third inoculation and again one to ten months after completing their primary course. All the sera were separated, stored at 4' C., and then submitted to in-vitro assays for pertussis antibodies. Diphtheria and tetanus responses to combined antigen in infants aged 3 months or over are known to be satisfactory (Barr et al., 1955 ; Butler and Barr, 1960) , therefore antitoxin titrations were not carried out. Similarly responses to three doses of trivalent oral poliomyelitis vaccine are known to be adequate (Perkins et al., 1963) .
Results

Laboratory Potency Tests
The vaccines were tested in guinea-pigs for diphtheria and tetanus potency by the methods required under the British Therapeutic Substances Regulations 1964, No. 1434, for unadsorbed vaccines and for pertussis by the mouse protection test (Kendrick et al., 1947) . The results are shown in Table  II . The addition of aluminium hydroxide increased the antigenic response to both tetanus and pertussis components but did not significantly alter the diphtheria potency. (Pittman and Cox, 1965) . The test showed that vaccine A was more toxic than vaccine B, which in turn was more toxic than vaccine C. The Standard Reference Vaccine was less toxic than A but more toxic than B or C (see Chart). All the vaccines more than satisfied the minimum standard of non-toxicity prescribed in the minimum requirements of the U.S. Government Regulations (1953 Regulations ( , 1961 ). The vaccines were tested for histaminesensitizing potency (Pittman, 1951) and found to differ significantly (P 0 01). The most sensitizing vaccine was A, vaccine B was of equal sensitizing potency to that of the Standard Reference Vaccine, and vaccine C was the least sensitizing.
The mouse weight gain test is believed to be the most reliable test in laboratory animals for measuring likely reactionprovoking properties of pertussis-contaiining vaccines in children (Pittman and Cox, 1965; Muggleton, 1967) . The trend in toxicity was also indicated from the results of the histaminesensitizing tests in mice.
Clinical Investigation
One hundred and sixty-eight infants completed their primary immunization schedule with one or other of the vaccines. Thirty-one failed to return after the first inoculation (19 after vaccine A, 7 after B, 5 after C) and a further eight failed to return after the second inoculation (five after A, three after C). Therefore 84% completed their course (71 % for vaccine A, 89% for B, and 93% for C). The incidence of reactions in the infants failing to attend for second or third injections was no greater than that seen in the corresponding group who completed their primary course. The higher incidence of reactions after first inoculations in infants receiving vaccine A may have accounted for the greater number of failures in this group.
Reactions following inoculations in those infants who completed their primary course are shown in Tables III, IV , and V. Where reactions were absent or so slight that they would not have been reported except on close questioning, these are grouped together and classified as "trivial or no reaction." There were no serious reactions in any of the three groups; no convulsions were reported, no cases of collapse, and no case in which persistent and high-pitched screaming was a feature (Hopper, 1961 ; Haire et al., 1967) . The incidence of generalized reactions to vaccine A was significantly higher than with either vaccine B or C (P<0 001), there was no significant difference between vaccines B and C (Table III) . There was a highly significant difference in the incidence of generalized reactions to the vaccines after the first injection (P<0 001), vaccine A producing far more than the other two, between which there was no significant difference. There was a similar though less significant finding after the second injections (P<0 05). Reactions were also more numerous after vaccine A at the third injection, but the figures are not in fact significant (P>0 2). reaction to the first (P<001); nine children had generalizedi reactions after all three injections with this vaccine. This association of reactions to serial doses was not seen with vaccine B or C.
The incidence of local reactions tended to be low, and not significant when taken together (Table IV) . However, there was a significant fall in the incidence for vaccine A with progression through the schedule (P<001) and a significant rise with vaccine B at the third injection (P<0 02). Vaccine A produced significantly more reactions at the first injection than B or C, and B more than A or C at the third. However, when. children returned for second or third injections in the series 24 subcutaneous nodules at the site of the previous injection were found after 112 inoculations with vaccine B and 22 after 130 with vaccine C. None occurred after vaccine A. One infant developed a " sterile abscess " after vaccine C, otherwise the nodules were small and uncomplicated. (Dolby and Vincent, 1965 found in nearly all normal human sera was used as the baseline and the numbers of enhanced titres are recorded (Table VI) .
The second method of measuring agglutinins is by scoring the presence or absence of agglutinins to agglutinogens 2 to 6.
o. with Table VII The significance of the weight gain test in mice was further emphasized. The difference in reactions to the various vaccines in children was most marked for the first injection, less for the second, and not significant at all for the third. The incidence of generalized reactions after plain vaccine was highest following first injections and decreased with progress through the primary course. This result was not influenced by those infants who failed to attend after their first inoculation, since the incidence of generalized reactions in that group was similar to that of the group who completed their schedule. This feature did not apply to injections with the adsorbed vaccines in this trial, where the incidence of generalized reactions was unaltered with progression through the course.
Reactions have rightly been attributed to the pertussis content (Hopper, 1961) and have been shown to be directly proportional to the number of pertussis organisms present (McFarlan et al., 1945; Bousfield, 1952) . However, a reduction in numbers of organisms/dose of plain vaccine might lead to an unacceptable loss of potency (Perkins, 1967 ---tion of alum-containing vaccines serves to emphasize the need for deep injection, preferably by the intramuscular route for these vaccines (Sauer and Tucker, 1954 ; Burland et al., 1968) . Few would disagree with the advisability of discontinuing pertussis vaccination in children who have suffered a severe generalized reaction to a previous dose of the vaccine. In the case of plain vaccine the wisdom of this may have been justified by the finding of a high incidence of generalized reactions to a second dose of antigens in children who reacted to the first. However, with the adsorbed vaccines generalized reactions were mild and infrequent, and recurrent reactions were not common in those infants who had reacted to a first dose of vaccine. The use of such a vaccine could result in fewer children losing the benefits of a full course of pertussis immunization.
Vaccination in almost all the children in this survey caused the appearance of specific agglutinins ; in this respect vaccines B and C were superior to A. There was considerable individual variation in amounts of specific agglutinins and of bactericidal antibody produced.
Conclusions
The value of the mouse weight gain test as an indicator of reaction-provoking tendencies in children is again shown, and it is suggested that it should continue to be applied to all vaccines containing pertussis antigen. The addition of aluminium hydroxide as adjuvant to diphtheria, tetanus, and pertussis combined 'vaccine served to increase antigen potency and significantly reduce the incidence of generalized reactions in children. A reduction by half in the number of pertussis organisms in the adsorbed combined vaccine did not further reduce reactions and therefore served no useful purpose.
Vaccines containing aluminium hydroxide are in widespread use for immunization against diphtheria and tetanus, and it is suggested that protection in infancy can best be obtained by using an adsorbed diphtheria, tetanus, pertussis vaccine.
